Department of Community Medicine, School of Medicine, University of Porto, Porto, Portugal
Opinion
Infliximab in the Treatment of Ankylosing Spondylitis: A New Frontier
Author(s): Alemidia Gulva*
DOI:
10.37421/2476-1958.2024.9.220